{"url_path":"/sec/erna/8-k/2026-07-02/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits.**","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-07-02","source_url":"https://www.sec.gov/Archives/edgar/data/748592/0001493152-26-031920-index.html","accession_number":"0001493152-26-031920","cik":"0000748592","ticker":"ERNA","issuer_name":"Ernexa Therapeutics Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/748592/0001493152-26-031920-index.html","primary_entity_key":"0000748592","primary_entity_name":"Ernexa Therapeutics Inc."},"word_count":83,"has_tables":true,"body_markdown":"**Item\n9.01 Financial Statements and Exhibits.**\n\n \n\n(d)\n*Exhibits*\n\n \n\n**Exhibit\nNo.**\n \n**Description**\n\n10.1\n \n[2026 Ernexa Therapeutics Inc. Omnibus Equity Incentive Plan](ex10-1.htm)\n\n104\n \nCover\nPage Interactive Data File (embedded within the Inline XBRL document)\n\n \n\n-2-\n\n \n\n \n\n**SIGNATURE**\n\n** **\n\nPursuant\nto the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by\nthe undersigned, hereunto duly authorized.\n\n \n\n \nErnexa\nTherapeutics Inc.\n\n \n \n\nDated:\nJuly 2, 2026\nBy:\n*/s/\nSanjeev Luther*\n\n \n \n\nSanjeev\nLuther\n\n \n \nPresident\nand Chief Executive Officer\n\n \n\n-3-"}